Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Cameron, Robert ^a   Davies, H R ^b  

^a New South Wales Government   (Australia)

^b NONE

Author keywords

Empyema, pleural *drug therapy ; Fibrinolytic agents *administration dosage ; Pleural effusion *drug therapy ; Pneumonia complications ; Randomized controlled trials as topic; Streptokinase *administration dosage

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE; UROKINASE;

CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONSERVATIVE TREATMENT; DEATH; DEBRIDEMENT; EFFUSION; EMBASE; EMPYEMA; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; INTERCOSTAL MUSCLE; LUNG SURGERY; MEDLINE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PARAPNEUMONIC EFFUSION; PLEURA CAVITY; POSTPNEUMONIC EMPYEMA; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SURGICAL DRAINAGE; SYSTEMATIC REVIEW; THORAX PAIN; TREATMENT FAILURE;

EID: 44949108353     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002312.pub3     Document Type: Review

References (59)

1. Bouros 1997 {published data only} *Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas N. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions. American Journal of Respiratory and Critical Care Medicine 1997;155(1):291-5.
2. Bouros 1999 {published data only} *Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. American Journal for Respiratory and Critical Care Medicine 1999;159(1):37-42.
3. Bouros D, Schiza SE, Drositis J, Tzanakis N, Papalexatos S, Mitrouska I, et al. Control study of intrapleural instillation of urokinase in the treatment of multi-loculated pleural effusion and empyema. American Journal of Respiratory and Critical Care Medicine 1998;157(3 Suppl):A65.
4. Schiza S, Bouros D, Maltezakis G, Drositis J, Tzanakis N, Siafakas NM. Intrapleural urokinase vs normal saline in the treatment of thoracic empyema: a randomized double blind study. European Respiratory Journal 1997;10(Suppl 25):455s.
5. Davies 1997 {published and unpublished data} *Davies RJO, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52:416-21.
6. Diacon 2004 {published data only} Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. American Journal of Respiratory & Critical Care Medicine 2004;170(1):49-53.
7. Maskell 2005 {published data only} Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, et al. First Multicenter Intrapleural Sepsis Trial (MIST1)Group. U.K. Controlled trial of intrapleural streptokinase for pleural infection. New England Journal of Medicine 2005;352(9):865-74.
8. Misthos 2005 {published data only} Misthos P, Sepsas E, Konstantinou M, Athanassiadi K, Skottis I, Lioulias A. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study. European Journal of Cardio-Thoracic Surgery 2005;28(4):599-603.
9. Tuncozgur 2001 {published and unpublished data} Tuncozgur B, Ustunsoy H, Dikensoy O, Topal M, Sanli M, Elbeyli L. Intrapleural urokinase in themanagement of parapneumonic empyema: a randomised controlled trial. International Journal of Clinical Practice 2001;55(10):658-60.
10. Bilaçeroglu 1997 Bilaçeroglu S, Cagirici U, Cakan A, Kumcuoglu Z, Perim K. Management of complicated parapneumonic pleural effusions with image-guided drainage and intrapleural urokinase or streptokinase: a controlled randomized trial. European Respiratory Journal 10;Suppl 25(325s).
11. Chin 1997 *Chin NK, Lim T. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997;111:275-9.
12. Chung 2003 Chung CL, Chen YC, Chang SC. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest 2003;123(4):1188-95.
13. Lim 1999 *Lim TK, Chin NK. Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. European Respiratory Journal 1999;13:514-8.
14. Talib 2003 Talib SH, Verma GR, Arshad M, Tayade BO, Rafeeque A. Utility of intrapleural streptokinase in management of chronic empyemas. Journal of the Association of Physicians of India 2003;51:464-8.
15. Thomson 2002 *Thomson AH, Hull J, Kumar R, et al. A randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002;57:343-7.
16. Davies 2007 Davies RJ. MIST2: Multi-centre intra-pleural sepsis trial (to assess whether Dnase or Alteplase improve pleural fluid drainage in pleural infection.). http://www.ctu.mrc.ac.uk/studies/mist2.asp (accessed 4/10/2007).
17. Aye 1991 Aye RW, Froese DP, Hill LD. Use of purified streptokinase in empyema and hemothorax. American Journal of Surgery 1991;161:560-2.
18. Berger 1990 Berger HA, Morganroth ML. Immediate drainage Is not required for all patients with complicated parapneumonic effusions. Chest 1990;97:731-5.
19. Bergh 1977 Bergh NP, Ekroth R, Larsson S, Nagy P. Intrapleural streptokinase in the management of haemothorax and empyema. Scandinvaian Journal of Thoracic and Cardiovascular Surgery 1977;11:265-8.
20. Cho 2000 Cho CH, Kwak SM, Park CS, Bae IY, Moon TH, Cho JH, et al. The effects of urokinase instillation therapy via percutaneous transthoracic catheter drainage in loculated pleural effusion: a randomised prospective study. European Respiratory Journal 2000;16(Suppl 31):579s.
21. Davies 1998 Davies CW, Lok S, Davies RJO. The systemic fibrinolytic activity of intrapleural streptokinase. American Journal of Respiratory and Critical Care Medicine 1998;157:328-30.
22. Davies 1999 Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. American Journal of Respiratory and Critical Care Medicine 1999;160:1682-7.
23. Fraedrich 1982 Fraedrich G, Hofmann D, Effenhauser P, Jander R. Instillation of fibinolytic enzymes in the management of pleural empyema. Thoracic Caridvascular Surgery 1982;30(1):36-8.
24. Godley 1984 Godley PJ, Randall CB.Major hemorrhage following administration of intrapleural streptokinase. Chest 1984;86:486-7.
25. Heffner 1995 Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. American Journal of Respiratory and Critical Care Medicine 1995;151:1700-8.
26. Henke 1992 Henke CA, Leatherman JW. Intrapleurally administered streptokinase in the treatment of acute loculated lonpurulent parapneumonic effusions. American Review of Respiratory Disease 1992;145:680-4.
27. Hippocrates Hippocrates. In: Lloyd GER editor(s). Hippocratic Writings (introduction by GER Lloyd). Penguin Classics, 1978.
28. Idell 1991 Idell S, Girard W, Koenig KB, McLarty J, Fair DS. Abnormalities of pathways of fibrin turnover in the human pleural space. American Review of Respiratory Disease 1991;144:187-94.
29. Idell 2005 Idell S. Update on the use of fibrinolysins in pleural disease. Clinical Pulmonary Medicine 2005;12(3):184-90.
30. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
31. Jerjes-Sanchez 1996 Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde J, Delgado R, Cicero R. Intrapleural Fibrinolysis with Streptokinase as an Adjunctive Treatment in Hemothorax and Empyema. Chest 1996; Vol. 109:1514-9.
32. Kerr 1991 Kerr A, Vasudevan VP, Powell S, et al. Percutaneous catheter drainage for acute empyema. New York State Journal of Medicine 1991;91:4-7.
33. Laisaar 2003 Laisaar T, Pullerits T. Effect of intrapleural streptokinase administration on antistreptokinase antibody level in patients with loculated pleural effusions. Chest 2003;123(4):432-5.
34. Landreneau 1995 Landreneau RJ, Keenan RJ, Hazelrigg SR, Mack M, Naunheim KS. Thoracoscopy for empyema and hemothorax. Chest 1995;109:18-24.
35. LeMense 1995 LeMense PG, Strange C, Sahn SA. Empyema Thoracis. Therapeutic management and outcome. Chest 1995;107:1532-7.
36. Lemmer 1985 Lemmer JH, Botham MJ, Orringer MB. Modern management of adult thoracic empyema. Journal of Thoracic and Cardiovascular Surgery 1985;90:849-55.
37. Light 1985 Light RW. Parapneumonic effusion and empyema. Clinical Chest Medicine 1985;6:55-62.
38. Light 1995 Light RW. A new classification of parapneumonic effusions and empyema. Chest 1995;108:299-301.
39. Light 1998 Light RW, Rodriguez RM. Parapneumonic effusions and empyema. Clinical Chest Medicine 1998;19(2):373-82.
40. Light 2000 Light RW, Nguyen T, Mulligan ME, Sasse SA. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 2000;178(1):13-8.
41. Moulton 1995 Moulton JS, Benkert RE, Weisiger K, Chambers JA. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary urokinase. Chest 1995;108:1252-9.
42. Ogirala 1988 Ogirala RG, Williams MH. Streptokinase in a loculated pleural effusion. Chest 1988;94:884-6.
43. Pothula 1994 Pothula V, Krellenstein DJ. Early aggressive surgical management of parapneumonic empyemas. Chest 1994;105:832-6.
44. Ridley 1991 Ridley P, Bainbridge M. Thoracoscopic debridement and pleural irrigation in the management of empyema thoracis. American Thoracic Society 1991;51:461-4.
45. Roupie 1996 Roupie E, Bouabdallah K, Delclaux C, Brun-Buisson C, Lemaire F, Vasile N, et al. Intrapleural administration of streptokinase in complicated purulent pleural effusions- a CT- guided strategy. Intensive Care Medicine 1996;22:1351-3.
46. Sahn 1993 Sahn SA. Management of complicated parapneumonic effusions. American Review of Respiratory Disease 1993;148:813-7.
47. Silverman 1988 Silverman SG, Mueller PR, Saini S, et al.Thoracic empyema. Management with image-guided catheter drainage. Radiology 1988;169:5-9.
48. Simpson 2003 Simpson G, Roomes D, Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax 2003;58(4):365-6.
49. Skeete 2004 Skeete DA, Rutherford EJ, Schlidt SA, Abrams JE, Parker LA, Rich PB. Intrapleural tissue plasminogen activator for complicated pleural effusions. Journal of Trauma-Injury Infection & Critical Care 2004;57(6):1178-83.
50. Strange 1993 Strange C, Allen ML, Harley R, Lazarchick J, Sahn SA. Intrapleural streptokinase in experimental empyema. American Review of Respiratory Disease 1993;147:962-6.
51. Temes 1996 Temes RT, Fabrizio F, Kesller RM, Pett SB, Wernly J. Intrapleural fibrinolytics in the management of empyema thoracis. Chest 1996;110(1):102-6.
52. Thommi 2000 Thommi G, Shehan C, Bell A, Coughlin N, McLeay M. Intrapleural instillation of TPA in the management of of complicated pleural effusions. Chest 2000;118(Suppl 4):S164.
53. Tillett 1951 Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of postpneumonic empyema. Journal of Thoracic Surgery 1951;21:275-97.
54. Tokuda 2006 Tokuda Y, Matsushima D, Stein GH, Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: A meta-analysis. Chest 2006;129(3):783-90.
55. Wait 1997 Wait MA, Sharma S, Hohn J, Nogare AD. A randomised trial of empyema therapy. Chest 1997;111:548-51.
56. Walker 2003 Walker CA, Shirki MB, Marva MT, Visconti J. Intrapleural alteplase in a patient with complicated pleural effusion. Annals of Pharmacotherapy 2003;37:376-9.
57. Zhu 2006 Zhu Z, Guo Y, Drake W, Bilaceroglu S, Misra HL, Light RW. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest 2006;129(6):1577-83.
58. Cameron 1999 Cameron R, Davies H. Intra-pleural fibrinolytic therapy for parapneumonic effusions and empyema. Cochrane Database of Systematic Reviews 1999, Issue 4.
59. Cameron 2004 Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database of Systematic Reviews 2004, Issue 1.